HomeInsightsEPS

Parenteral Drugs (india) Ltd EPS

Parenteral Drugs (india) Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Aug 21, 2023)

stocks purchased

1.3 K

Stocks Traded

(Aug 21, 2023)

Last Updated on: Nov 14, 2024

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

EPS

₹ -43.12

Last updated on: Aug 21, 2024

Key Highlights

  • The Earning per Share of Parenteral Drugs (India) Ltd is ₹ -43.12 as of 21 Aug 23.

Company Fundamentals for Parenteral Drugs (India) Ltd

Market Cap

10 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

0.0

Day’s High *

3.39

Day’s Low

3.08

DTE *

-0.1

ROE *

15.6

52 Week High

3.39

52 Week Low

0.0

ROCE *

7.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20233.39
14 Aug 20233.24
24 Jul 20233.09
17 Jul 20233.25
10 Jul 20233.42
03 Jul 20233.59
26 Jun 20233.77
19 Jun 20233.96
12 Jun 20233.85
05 Jun 20234.05

SWOT Analysis Of Parenteral Drugs (India) Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Parenteral Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Parenteral Drugs (India) Ltd

Market Value

10

-1.0 X

Value addition

Asset Value

234

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Revenue of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Parenteral Drugs (India) Ltd News Hub

News

Parenteral Drugs (India) to conduct board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 3...

Read more

19 May 202215:25

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

05 Feb 202215:19

News

Parenteral Drugs (India) to convene EGM

Parenteral Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Com...

Read more

03 Feb 202216:49

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 2...

Read more

31 Jan 202211:36

News

Parenteral Drugs (India) to hold board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

06 Nov 202116:34

News

Parenteral Drugs (India) AGM scheduled

Parenteral Drugs (India) announced that the 37th Annual General Meeting (AGM) of the compa...

Read more

27 Aug 202114:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Parenteral Drugs (India) Ltd

What is the EPS of Parenteral Drugs (India) Ltd stock?

The Earnings Per Share (EPS) of Parenteral Drugs (India) Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Parenteral Drugs (India) Ltd EPS calculated?

The EPS of Parenteral Drugs (India) Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Parenteral Drugs (India) Ltd report its EPS?

Parenteral Drugs (India) Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Parenteral Drugs (India) Ltd EPS?

Factors that influence the EPS of Parenteral Drugs (India) Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Parenteral Drugs (India) Ltd EPS growth indicate future performance?

Yes, consistent growth in Parenteral Drugs (India) Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*